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Introduction: The Good Samaritan Provision of Act 139 was implemented in Allegheny County, 
PA in 2014 to serve as an intervention to curb opioid related overdose deaths. The Good Samaritan 
Law provided legal immunity to witnesses of overdoses and those overdosing in order to reduce 
barriers and encourage residents to call 911. 
Objective: Our study evaluated the effectiveness of the Good Samaritan Provision of Act 139. 
The purpose was to determine whether the implementation of the provision changed 911 calling 
behavior. 
Methods: Allegheny CountyStat provided 911 dispatch data for 2011 to 2018. We studied whether 
there was an increase of overdose related 911 dispatches after the implementation of the Good 
Samaritan Law using an interrupted time series model. To account for confounding, the correlation 
between opioid related overdose deaths and overdose related dispatches was evaluated at annual 
intervals. 
Results: The interrupted time series model was not statistically significantly (p=0.48). The annual 
correlations between opioid related overdose deaths and overdose related dispatches found that 
only 2016 and 2017 were strongly positively correlated; with the increase of overdose deaths there 
was an increase of overdose related dispatches. 
 v 
Conclusion: The interrupted time series model results show that the number of overdoses related 
911 dispatches did not follow a predicted upward trend in increased calls. However, this does not 
mean that there was no change in calls, only that the change in the number of dispatches post 
intervention was not linear. Results from the 2016 and 2017 correlations indicate that there was no 
association in the number of overdose related dispatches attributable to the GSL. Instead the rapid 
increase of overdose deaths may have caused the increase in calls.  The evaluation the Good 
Samaritan Provision of Act 139 has public health significance because it serves an opportunity to 
understand the barriers that surround this intervention. This law is one step of many, put into place 
to curb opioid related overdose deaths, which is currently a public health crisis. Evaluating the 
effectiveness of the Good Samaritan Provision of Act 139 allows the county to learn what is 
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1.1 Brief History of Opioid use in the United States 
Opioid misuse and overdose has had a devastating effect in the US. In 2016 and 2017, 
approximately 90,000 individuals died from an opioid related overdose (“Drug Overdose Deaths 
| Drug Overdose | CDC Injury Center,” n.d.), more than the American causalities of the Vietnam 
War (“Pain Manag. Opioid Epidemic,” 2017).  However, opioid use has been present in the US 
since the introduction of morphine in the 19th century. Bayer marketed heroin in the 1870’s as a 
less addictive form of pain relief.  During this time opium, heroin, and cocaine were used as 
medication and in surgeries. Subsequently, cases of overdose and addiction emerged. Doctors 
were aware of its dangers but continued to prescribe morphine. In the early twentieth 
approximately 200,000 people were addicted to opium-based drugs. This prompted the 
introduction of the 1906 Pure Food and Drug Act, which required patent medicines containing 
opiates to be labeled as ‘dangerous or addictive’. This continued with the 1914 Harrison Narcotic 
Tax Act which created a ‘registry of all those who produce, import, manufacture, dispense, or 
give away any product of the poppy or coca leaf.’(deShazo, Johnson, Eriator, & Rodenmeyer, 
2018), after which regulation continued to make possession and production of heroin illegal 
(deShazo et al., 2018). Heroin addiction rose once again after the Vietnam War among veterans, 
which prompted presidential action and lead to new recovery programs. However, in the 1990's 
the idea of pain and its treatment began to shift to medication. In 1995, pain was elevated to be a 
vital sign. Doctors began to routinely access pain and which prompted doctors to treat pain by 
prescribing medication (Morone & Weiner, 2013). 
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1.2 Current Crisis 
The stem of the current crisis began with physicians in the 1990’s prescribing opioid pain 
relievers at higher rates. While there was a general fear of making patients dependent on opioid 
medication, pharmaceutical companies assured the health care community that prescription opioid 
pain relievers were not addictive. Alongside creating this narrative pharmaceuticals companies 
aggressively marketed their opioids for pain. Purdue Pharma, producer of Oxycontin, spent 200 
million dollars to promote the drug in 2001. Prescriptions of oxycontin went up 10-fold to 
approximately 6.2 million prescriptions next year (Vadivelu, Kai, Kodumudi, Sramcik, & Kaye, 
2018). ‘Purdue Pharma marketing also included organizing 20,000 pain education programs and 
40 all-expense-paid conferences for 5000 physicians’ (Vadivelu et al., 2018). Additionally, they 
provided free coupons and targeted pain management physicians with sales representatives with a 
rewards system (Vadivelu et al., 2018). This created a system where physicians were encouraged 
to over-prescribe.  
Not only did the amount of prescriptions increase, but the opioid concentrations within 
medications increased. The distribution of morphine milligram equivalents per person increased 
more than 600% from 1997 to 2007(“CDC Grand Rounds: Prescription Drug Overdoses — a U.S. 
Epidemic,” n.d.).  With a combination of more prescriptions at higher doses this created a whole 
new generation who were dependent on opioids. This led to what the CDC labels as the ‘first wave 
of opioid related overdose deaths’, where the majority of overdose deaths involved prescription 
opioids  (“Understanding the Epidemic | Drug Overdose | CDC Injury Center,” n.d.). The second 
wave of the opioid crisis in 2010. Starting in 2010 there was rapid increase in overdose deaths 
involving heroin(“Understanding the Epidemic | Drug Overdose | CDC Injury Center,” n.d.). In 
2013 the third wave started, involving a massive increase in synthetic opioid related overdose 
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deaths. From 2016 to 2017 there was a 47% increase in overdose deaths related to synthetic 
opioids. Specifically, majority of these overdoses involved fentanyl (“Fentanyl | Drug Overdose | 
CDC Injury Center,” n.d.). 
1.3 Opioid Epidemic in Pennsylvania 
In 2017, Pennsylvania had the third highest number of fatal overdoses within the US 
(“Drug Overdose Deaths | Drug Overdose | CDC Injury Center,” n.d.). From 2015 to 2017, the 
rate of drug-related overdoses increased in Pennsylvania from 26 per 100,000 to 43 per 100,000, 
with the national average of 22. In 2017, Allegheny County was in the top four counties with the 
most drug related overdoses, with a death rate of 60 people per 100,000(The Opioid Threat in 
Pennsylvania, 2018).  
Allegheny County’s opioid related overdose deaths follow the national trends of the 
CDC’s 3 waves of the opioid epidemic. From 1999 to 2011 prescription opioids were the leading 
type of opioid found in opioid fatal overdoses after which heroin became the predominant 
substance found in fatal opioid overdoses from 2011 to 2014 (Cherna & Hacker, 2016). From 
2015 to 2017, heroin was found in approximately 50% of all overdoses in which 80% were 
opioid related. Then beginning in 2017 there was a rise of fentanyl found in opioid related 
overdose death. Fentanyl was found in 70% in all overdose deaths in Allegheny County from 
2017 to 2018 in which 80% were opioid related (“Death Data Overview – OverdoseFreePA,” 
n.d.). From 2015 to 2017, Allegheny County saw a 77 percent increase in opioid related 
overdose deaths, with 352 opioid related deaths in 2015 and 624 in 2017. 
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This shift from heroin to fentanyl may be due to its easy production and increased 
potency. Fentanyl was first approved for treatment for severe pain, specifically for cancer related 
pain. This drug is a synthetic opioid that is 50 to 100 times more potent than morphine. However 
now, it is often synthesized illegally and can be indistinguishable from heroin. Fentanyl is 
cheaper and quicker to make compared to heroin; it is made from chemicals that are more readily 
available than the opium crop that is used to make heroin (Han et al., 2019). Fentanyl’s lower 
costs along with a high potency contributed to the rise of fentanyl being found in increasing 
amounts in fatal overdoses. While some sought out fentanyl illicitly, often many were unaware 
that fentanyl was present in their heroin. The increased potency meant that the amount one 
needed to take to overdose was much less than that of heroin. This led to individuals 
unknowingly consuming lethal amounts of fentanyl (Han et al., 2019).  
1.4 Background on Good Samaritan Laws 
To fully understand the Good Samaritan Law (GSL) under Act 139 it is worth exploring 
the source of Good Samaritan laws. The origin of a ‘Good Samaritan’ lies in a biblical parable 
which defines a good Samaritan as someone who administers aid to another person without any 
expectation of compensation but does so out of good faith (West & Varacallo, 2019). In modern 
day the good Samaritan law was extended to protect volunteers after they offered aid. 
Specifically, the Cornell Law School Legal Information Institute explains the Good Samaritan 
Rule to be, “The doctrine that protects a volunteer who comes to the aid of an injured or ill 
stranger from being sued for contributory negligence, as long as the volunteer aid-giver (the 
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Good Samaritan) acted with reasonable care(“Good Samaritan Rule | Wex | US Law | LII / Legal 
Information Institute,” n.d.).” 
These laws are relevant during emergency situations where consent is implied if the 
victim is unresponsive or unconscious (West & Varacallo, 2019).  Now the overall goal of Good 
Samaritan Laws is to encourage citizens to help one another without the fear of facing any 
repercussions. Since 1959 every state has some form of Good Samaritan laws. The first Good 
Samaritan laws in America were passed to protect medical professionals if they choose to help 
victims during an emergency. The law protected them from being sued for reasonable mistakes, 
as long as they acted in good faith and were not reckless in their response (Brandt, 1983). In 
recent years, Good Samaritan laws have extended protections to people who are taking part in 
illegal drinking or drug use with the intention that individuals will be more likely to call 911 and 
therefore prevent avoidable deaths. 
1.5  Overview of Act 139 
Act 139 in the state of Pennsylvania was passed on September 30, 2014 and went into 
effect on November 28, 2014. This law put into place two interventions. First it expanded 
naloxone administration to all first responders and allowed naloxone kits to be distributed to 
laypeople in the community (Act 139 Fact Sheet, n.d.). Before this law, only paramedics and 
intermediate-level EMT’s could administer naloxone. Further this law created a standing order 
where anyone could obtain naloxone without a prescription from a pharmacy and allowed local 
organizations to freely distribute naloxone within the community. Second it implemented a Good 
Samaritan Law (GSL) which provides limited legal immunity from being charged and 
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prosecuted for drug possession for an individual experiencing or witnessing an overdose when 
they seek help by calling 911. 
1.6 Good Samaritan Provision of Act 139 
Often, bystanders of overdoses do not seek medical aid out of fear of charged for drug 
related crimes or being arrested for violating parole or probation. Act 139 Good Samaritan 
Provision addresses this issue with limited legal immunity. The premise is that when more 
people call 911, there will be less fatal overdoses. When one calls 911 in these situations, the 
witness who is calling is entitled to some forms of immunity. Immunity in these situations means 
that the person overdosing or witnessing an overdose will not be charged with possession of a 
controlled substance or violation of parole if they are on probation (Act 139 Fact Sheet, n.d.).  
However, for immunity to apply specifically within Act 139, certain conditions need to be met 
by the caller and the person who is experiencing an overdose. First, one needs to report or call 
911 ‘in good faith’ meaning they believe the person overdosing is in ‘need of immediate medical 
attention’ and medical attention is needed to prevent death. Second, the person who calls needs 
to provide their own name, location, and cooperate with law enforcement. Third, the caller needs 
to remain with the person overdosing until a first responder has arrived. This law, however, does 
not give a person immunity from being charged with the intention to distribute or sell drugs or 
drug induced homicide. This provision also does not protect against arrests related to an ongoing 
investigation or if an officer discovers drug use occurring before someone calls or independently 
gains knowledge of the situation (2014 Act 139 - PA General Assembly, n.d.). Though this law 
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has good intentions it may still discourage individuals from calling 911 due to the fear of being 
arrested.  
One way fear is growing among residents of Allegheny County is the exponential rise of 
drug delivery resulting in death or drug induced homicide. The Pennsylvania Courts explains the  
drug delivery resulting in death charge to be when “A person commits a felony of the first degree 
if the person intentionally administers, dispenses, delivers, gives, prescribes, sells or distributes 
any controlled substance or counterfeit controlled substance, and another person dies as a result 
of using the substance (2014 Act 139 - PA General Assembly, n.d.)”. Pennsylvania saw a 1,267 
percent rise in drug delivery resulting in death charges from 2013 to 2017. Starting in 2013 there 
were only 15 cases but in 2017 there 205 new cases (Drug Delivery Resulting in Death Citations 
at Five-year High, 2018). This rise in cases could create distrust in witnesses and deter them 
from calling 911.  
Barriers to calling 911 were addressed in a 2017 study done in Baltimore. Latimore and 
Bergstein conducted 22 in-dept interviews with needle exchange clients to understand their 
decision to call 911 when witnessing an overdose. Overall, this study revealed that most 
participants would not call 911 due to mistrust of law enforcement. Many were afraid of losing 
housing or custody of children while also fearing repercussions from local drug dealers. Further, 
75 percent of participants did have knowledge of the GSL (Latimore & Bergstein, 2017). This 
shows that even with a GSL in place, people are hesitant to call 911.  
Further there is no guarantee that residents are aware of this provision. There is no 
indication that the state of Pennsylvania did any outreach or marketing of Act 139 GSL. Studies 
reveal that awareness of a GSL is necessary to be effective.  Jakubowski et. al. conducted a study 
in New York where a GSL was implemented. This was a prospective longitudinal study that 
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analyzed an educational program which taught participants about the GSL and overdose 
response. The researchers implemented follow-up surveys at three, six, and twelve-months in 
order to analyze participants knowledge of GSL and their response when they witnessed an 
overdose. The study concluded that there was an association with awareness of GSL and their 
willingness to call 911. They found that witnesses of an overdose who had accurate knowledge 
of the GSL, were three times more likely to call 911 then someone who had incorrect knowledge 
(Jakubowski, Kunins, Huxley-Reicher, & Siegler, 2018).  
However, this study did not address whether this law had any impact on the larger 
population of New York. Ngugen and Parker study builds upon this idea and analyzes the 
effectiveness of the New York’s GSL. Ngugen and Parker examined the difference of accidental 
heroin overdose ED visits and inpatient admissions from 2010 to 2012. They compared the ED 
visits in New York to New Jersey. In New Jersey, a GSL law had not been implemented. The 
incident rate ratio (IRR) of accidental heroin overdose ED visits between the states was 1.34 
(95% CI = 1.00, 1.86), where New York saw an increase of specified ED visits (Nguyen & 
Parker, 2018). This reveals that people were more likely to go to the emergency room when 
overdosing when a GSL was in place. But this study did not assess whether this was related to 
overall rise of overdose deaths in either state. 
1.7 Naloxone Distribution 
Beginning in 2015, Act 139 allowed pharmacies and organizations to distribute naloxone 
without a prescription. Naloxone is also known as its brand name Narcan, is a medication 
designed to rapidly reverse an opioid overdose. Naloxone serves as an antidote to the toxicity of 
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opioids and allows a victim to regain the ability to breathe (Shaw et al., 2019). It has no risk of 
abuse with no known side effects. The Allegheny County Health Department (ACHD) 
distributes naloxone to residents and organizations at no charge. From 2015 to 2018, ACHD 
alone had distributed close to 15,000 kits to local organizations whom later gave naloxone to 
community members who are likely to witness an overdose. Naloxone is generally distributed as 
part of the ACHD Opioid Overdose Prevention Program (OPP), which covers how to identify the 
symptoms of an opioid related overdose, how to administer naloxone, and to call 911.   
An evaluation of naloxone’s effectiveness was done in 2008 in New York City, when 
naloxone was first being widely distributed. Based on 122 participants who took part in an OPP, 
58.2% reported using naloxone in response to witnessing an overdose. Of those who had 
naloxone administered on them, 83% were revived (Piper et al., 2008). Specifically, within 
Allegheny County, Prevention Point Pittsburgh (PPP), which is an organization that does clean 
needle exchange and naloxone distribution in Allegheny County, conducted an evaluation of 
their OPP from 2005 to 2008. Their report included 426 individuals who took part in an OPP, 89 
of those participants successfully administered naloxone in 249 instances of witnessing an 
overdose (Bennett, Bell, Tomedi, Hulsey, & Kral, 2011). Both evaluations indicate the 
effectiveness of both naloxone and OPP’s.  
1.8 Gaps in Knowledge 
Good Samaritan Laws surrounding the opioid crisis have been evaluated in the past. 
Researchers evaluated change in number of ED visits and surveyed people’s willingness to call 
911 after being educated about a GSL. However, many of these studies do not address external 
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factors, such as naloxone distribution and the rise of overdose deaths. It is still necessary to 
address these factors to fully understand how GSL overall contributes to the opioid epidemic. 
Existing literature examined various measures to study Good Samaritan Laws, however they do 
not specifically address the number of 911 dispatches. Specifically, within Allegheny County 
there is no such evaluation of Act 139 Good Samaritan Act that examined the time span of 2011 
to 2018. The purpose of this evaluation was to examine overdose related 911 dispatches and how 
that rate changed before and after the implementation of the Good Samaritan law in Allegheny 
County.   
1.9 Public Health Significance 
The rise of opioid overdose has been incredibly rapid. In 2017, opioid related overdose 
deaths were six times higher than in 1999 (“Opioid Data Analysis and Resources | Drug 
Overdose | CDC Injury Center,” n.d.). The Good Samaritan Law of Act 139 was passed as an 
intervention to curb overdose deaths. Its intention was to reduce barriers to calling 911 when one 
is witnessing an overdose and acting to prevent a person’s death. It is necessary to evaluate 
whether this law was doing what it intended. Specifically, during a time when homicide charges 
against those witnesses and victims of overdoses have increased. This has created an additional 
barrier for someone calling 911. Further the rise of overdose deaths and increase of naloxone 
distribution are unique confounders that are necessary to account for to understand how the GSL 
is impacting overdose related 911 dispatches in Allegheny County. 
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2.0 Objective 
To fully understand the impact of the Act 139’s Good Samaritan Law, we examined the 
volume of overdose related 911 dispatches before and after the implementation of the law in 
Allegheny County. The intention of the law was to encourage those witnessing an overdose to 
call 911 without the fear of legal repercussions. Analyzing the volume of calls before and after 
the implementation of the law enabled us to determine whether there was an increase in overdose 
related dispatches attributable to the GSL. We also examined different confounders including 
opioid related overdose deaths. 
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3.0 Methods 
3.1 Data Acquisition 
Allegheny County’s CountyStat provided overdose related 911 dispatches along with 
total counts of all 911 dispatches in Allegheny County from 2011 to 2018.  Allegheny County’s 
Emergency Services collected these data from municipalities’ Emergency Medical Services 
(EMS). The number of municipalities participating in collecting these data varies throughout the 
years however in 2018, 111 out of 130 Allegheny County’s municipalities collected and reported 
their EMS data. EMS dispatchers record information about the call, determine the location of the 
emergency, and categorize the call based on information relayed over the call. Some examples of 
these codes include: choking, traffic-with injuries, and abnormal breathing. We specifically 
examined dispatches that were coded as an overdose from 2011 to 2018. Choosing these years 
gave us an equal amount of data for before and after the enactment of the GSL in 2014.  
In order to gain insight into how other factors contributed to overdose related dispatches we also 
examined accidental fatal opioid overdoses. Counts and dates of accidental fatal opioid 
overdoses were obtained from the Western Pennsylvania Reserve Data Center (WPDRC).  
3.2 Data Preparation 
We first stratified our data which included 2 groups: overdose related 911 
dispatches(n=24,930) and all dispatches (n= 6,254,434) into pre- and post-intervention time 
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periods. The Good Samaritan Law was enacted in September 30, 2014 (quarter 3).  However, we 
choose to designate our pre-intervention time period as January 1, 2011 to December 31, 2014 
and our post-intervention time period being from January 1, 2015- December 31, 201 to account 
for any delay in implementation. It is common practice to push back the start the time of an 
intervention within in time series data, to account for delays in intervention implementation 
(Linden & Arbor, 2015). We aggregated dispatches quarterly and monthly to examine the trends 
over an 8-year time period.  This allowed us to see smooth trends while still holding onto 
multiple data points. We also calculated the quarterly volume of overdose related calls as the 
number of overdose related dispatches over the total number of total 911 dispatches. 
We also quarterly aggregated counts of dispatches for using the same pre and post 
intervention broken down for the 211 neighborhoods and municipalities that were present in the 
dispatch records. 
3.3  Statistical Analyses 
In order to visualize how overdose related 911 dispatches were changing over time, 
quarterly aggerated counts, the volume of overdose related dispatches were plotted quarterly, 
opioid related overdose deaths from 2011-2018. Further we plotted annual counts of all 911 
dispatches and quarterly. To examine whether there was a change in volume of dispatches we 
conducted an interrupted time series analysis (ITSA) using STATA 15. ITSA is a quasi-
experimental research design used to analyze time dependent data with pre and post intervention 
data. It has been used in the past to evaluate community policy interventions (Linden & Arbor, 
2015). This model looks at counts of events at specific time points. It calculates and examines a 
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moving average before and after the implementation of an intervention. ITSA measures whether 
these moving averages are the same pre and post intervention. In this model the pre-intervention 
group serves as a counterfactual by projecting its slope into the treatment period. The pre-
intervention group for this analysis was the aggregated volume of 911 overdose dispatches 
quarterly from 2011 to 2015. The post intervention group was the aggregated volume of 911 
overdose dispatches quarterly from 2015 to 2018 (table 8).  
When using time specific data, there is a risk of autocorrelation. Autocorrelation is the 
amount of correlation that exists between data points that occur close in time to one another or at 
certain times of the year. The ITSA model uses an ordinary least squares (OLS) regression which 
is commonly known as linear regression. The model creates Newey-West standard errors to 
account for autocorrelation of data. Newey West standard errors are commonly used in models 
where standard assumptions of regression analysis are not applicable and is specifically used for 
time series data. The standard errors adjust for autocorrelation and heteroskedasticity.  The ITSA 
model requires we create an initial model using zero lags, meaning that no autocorrelation exists. 
After creating the initial model, we were able test the initial model for autocorrelation. We found 
autocorrelation present at the six order. This means that 6 quarters preceding the start of the 
intervention, which was Quarter 3 of 2013, would be used to predict the projected intervention 
slope in order to account for autocorrelation. We then created a final model with 6 lags. The 
ITSA model in STATA outputs a graph which shows a post trend of the predicted slope 
calculated using pre-intervention data. This is projected into the post intervention time period 
after time 17, which is known as the post trend. The model measures whether this predicted post 
trend is similar to actual data in the post intervention time period using OLS regression. The null 
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hypothesis of this model holds that the intervention did not produce a change in the post trend 
slope, which in this case is the volume of overdose related calls in the post intervention period.  
One confounding variable that may affect the relationship between the enactment of the 
GSL and number of overdose related dispatches is the rise of overdose deaths. One would expect 
with that with rise of fatal opioid overdoses that the number of overdose related 911 dispatches 
would also rise. To examine the relationship of overdose dispatches with overdoses deaths, we 
calculated the spearman correlations of both variables using SAS 9.4. Spearman correlations 
were used because our data were not normally distributed.  
In order to do evaluate our correlations, we aggregated counts of opioid related overdose 
deaths and overdose related dispatches into monthly counts. We then evaluated using spearman 
correlation the annual time intervals, the pre-intervention and post intervention time periods, and 
the total duration of the study time period from 2011 to 2018 using monthly aggregated counts of 
both variables. 
3.4 Results 
3.4.1  Descriptive Results 
We plotted quarterly aggerated counts of overdose related dispatches (figure 1) and the 
volume of overdose related dispatches (figure 2). There was a peak of quarterly counts 
dispatched from second quarter of 2016 till the third quarter of 2017, the highest number of 
counts 1438 in quarter 3 of 2016. From quarter 1 of 2015, the start of the intervention, to quarter 
3 of 2016 there was 238.35 percent increase in quarterly counts of calls. Concurrently there was 
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a similar pattern with the volume of calls increasing and peaking from 2016 to 2018 (figure 2) 
Further the number of all 911 dispatches steadily increased every year from 2011 to 2018 (figure 
4). Quarterly opioid related overdose deaths were plotted and can be found in figure 3. We found 
a peak of opioid related overdose deaths in 2016 to 2017, similar to overdose related dispatches. 
We found that Shaler Township had the highest rate of dispatches based on a population 
of 10,000 of overdose related dispatches before the enactment of the GSL (table 1) while Penn 
Hills had the highest count of overdose related dispatches (table 3). When examining after the 
enactment of the GSL, Shaler Township had the highest rate of dispatches based on a population 
of 10,000 of overdose related dispatches with a 34 percent increase in dispatches (table 2) but the 
Golden Triangle had the greatest count of overdose related dispatches with a 345 percent 
increase in counts of overdose related dispatches (table 4).  
3.4.2  Statistical Model Results 
The ITSA model y-intercept was estimated to be 0.27% of volume of dispatches with a 
significant increase of 0.002% annually (p<0.0001). The model was not able to estimate a 
statistically significant change for the first year or the second year (table 5). Figure 6 displays the 
post trend line as a solid line and shows the post intervention overdose related dispatch counts 
did not follow the post trend slope of a gradual increase. Between quarter 3 of 2016 to quarter 3 
of 2017, Figure 6 there was a positive change of calls beyond that which was predicted. 
However, outside of those time points the post intervention counts fall below the predicted slope. 
The post trend was not statistically significantly (p=0.48) and therefore we cannot reject the null 
hypothesis (table 6). This means statistically the number of overdoses related 911 dispatches did 
not follow a predicted upward trend in increased calls.  
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The annual correlations of overdose deaths and overdose related dispatches revealed that 
the relationship was not statistically significant outside of 2016 and 2017 (table 7). The increase 
of opioid related death was positively correlated with the increase in 911 dispatches in 2016 
r(10)=0.91 p<0.0001and 2017 r(10)=76, p=0.004. In the pre-intervention time period (2011-
2014) opioid related overdose deaths and overdose dispatches were weakly positively correlated 
r(46)=0.17485, p=0.24. In the post intervention time period (2015-2018) opioid related overdose 
deaths and overdose dispatches were strongly positively correlated r(46)= 0.73, p <0.0001 (table 
7).   
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4.0 Discussion 
The intention of this study was to examine whether there was a positive change in 
overdose related dispatches after the implementation of Act 139’s Good Samaritan Law. We 
compared the number of overdose related dispatches 4 years prior and 4 years after the GSL was 
passed using an interrupted time series model. We found that the volume of overdose related 911 
dispatches after the GSL was implemented did not follow the projected slope, which was a 
gradual positive increase. The post intervention overdose related dispatches were not linear, 
instead they had a positive peak in 2016 and 2017. The post intervention volume of overdose 
related 911 dispatch not following it’s predicted linear increase, indicate that there may be other 
factors at play.  
Confounders in this study included opioid related overdose deaths and naloxone 
distribution within Allegheny County. Opioid related overdose deaths were examined by 
evaluating the correlation of overdose related dispatches and opioid related overdose deaths from 
2011 to 2018. We found that in the years 2016 and 2017, the increase of opioid related overdose 
deaths was positively correlated with the increase of overdose related dispatches. This follows 
along strongly with the general trend of overdose deaths which peaked the between the years of 
2016-2017 (figure 3). None of the other post intervention years had a statistically significant 
relationship. This signals that there was not a change in number of overdose related dispatches 
simply due to the GSL. Instead the rapid increase of overdose deaths was causing an increase in 
calls.   
Additionally, we found that ACHD’s naloxone distribution began in 2016 during the 
peak year of overdose deaths and overdose related dispatches. Naloxone distribution also 
 19 
increased every year from 2016 to 2018 (figure 5). ACHD outreach workers hold naloxone 
trainings at local organizations and hold tabling events to teach people in the community on what 
naloxone is and how to use it. In their trainings they instruct those administering naloxone to call 
911; instructions to call 911 are also found on the naloxone kit that they distribute. This 
education may have also affected the rate of overdose related 911 dispatches. Further with 
naloxone being readily available, in many instances at no additional cost, people may no longer 
feel the need to call 911 if they are able to revive victims of an overdose on their own. This may 
also explain the decline of overdose related 911 dispatches starting in 2018. ACHD pharmacy 
collects data on the name of the organization, the number of requested kits, and the location of 
the organization picking up kits. No data exists on how many kits are eventually distributed or 
further used in the community or where those organizations are distributing to. Due to this 
limitation we were unable conduct any further analysis on naloxone distribution.  
Fentanyl was also increasingly found in overdose deaths. Fentanyl was found in 70% in 
all overdose deaths in Allegheny County from 2017 to 2018 in which 80% were opioid related 
(“Death Data Overview – OverdoseFreePA,” n.d.). There are increasing reports of naloxone 
being unsuccessful to revive people even with multiple doses. Further research on heroin 
overdose indicates the window of risk of death is at least 20 to 30 minutes (Han et al., 2019). 
However fentanyl when taken intravenously, can cause an overdose death with life-threatening 
repository distress within 2 minutes (Han et al., 2019). This increasing lethality of fentanyl and a 
complicated overdose response maybe another reason for an increase of calls during the fentanyl 
wave in Allegheny County. People may not have felt equipped to respond with simply naloxone 
if they saw instances of it being ineffective, prompting individuals to call 911 more frequently 
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than before. However, there is not one variable or factor that can be pinpointed as the reason for 
increased overdose related 911 dispatches from 2015 to 2018. 
There are limitations to this study that can inform future research. One major limitation is 
that our data violated ITSA assumption of linearity. This meant we were not able to conclusively 
evaluate the change in overdose related dispatches. In the future, having data that spans over a 
longer time period would allow us to see if the number of overdose related dispatches continued 
to increase in a more linear fashion. This would allow for a more conclusive ITSA model testing. 
Further using a model that accounts for non-linearity would have been more appropriate and 
could be used in future research. 
Also, the majority of municipalities report to the county their 911 dispatches, but not all 
do so. With the coming years, collecting data from additional or all municipalities will allow for 
a more in-depth analysis of how different municipalities vary in their overdose related 
dispatches. Specifically, looking at racial distributions in different municipalities and how that 
affects 911 dispatch rates would give further insight into how to the GSL is being disseminated 
in different communities. Additionally, we do not know how many people are aware of the 
current GSL and/or how individuals feel about it. In other studies examining the GSL related to 
overdoses there have been different methods of investigating these types of question. One study 
done in Rhode Island looked at the socioeconomic factors associated with having awareness of 
overdose related GSL using a logistic regression model. They found older age, white race, 
awareness of naloxone, and various other factors were associated with awareness of the GSL 
(Evans, Hadland, Clark, Green, & Marshall, 2016). 
Further a crucial question that remains to be answered is how the fear of law enforcement 
effects individual's willingness to call 911 when witnessing an overdose. In a study done in the 
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state of Colorado, researchers conducted semi-structured interviews with individuals who inject 
drugs, reversed one or more overdoses, and attended a naloxone educational event. They found 
that most were afraid to call 911 after witnessing an overdose because they believed they would 
be arrested. This fear persisted regardless of their knowledge of an existing GSL (Koester, 
Mueller, Raville, Langegger, & Binswanger, 2017). Conducting similar qualitative studies within 
Allegheny County would greatly contribute to our understanding the effectiveness of the GSL. 
This study was a first step examining whether the Good Samaritan Law within Act 139 
had a positive impact on overdose related 911 dispatches in Allegheny County, PA. We found 
that overdoses related dispatches did not follow the predicted projected slope of a gradual 
increase. There are various other factors to consider in the future which include conducting 
qualitative research into general awareness and sentiment towards the GSL while also controlling 
for the changes in opioid related overdose deaths. 
In conclusion, evaluation of the Good Samaritan Provision of Act 139 has public health 
significance because its primary purpose is to serve an intervention to curb opioid related 
overdose deaths. It is necessary to evaluate whether this law is doing what is intended and 
reducing barriers to calling 911. This allows the county to see what is working and where there 
are gaps that need to be addressed. This evaluation can inform future legislation and outreach 
work focused on reducing opioid related overdose deaths. 
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Appendix Tables and Figures 
Table 1 Top 10 Neighborhoods with the most overdose dispatches based on rate of calls per 10,000 for 2011-
2014  in Allegheny County, PA (pre-interventon) 
 
Municipality Number of Records 2010 Census Data Rate of Calls per 
10,000 
Shaler Township 142 639 444.44 
North Shore 21 303 138.61 
Golden Triangle 197 3629 108.57 
East Allegheny 70 2136 65.54 
Allentown 64 2500 51.2 
Windgap 31 1,369 45.29 
Millvale 82 3744 43.8 
Knoxville 82 3,747 43.77 
South Side Flats 140 6,597 42.44 
Stowe 133 6362 41.81 
 
 
Table 2 Top 10 Neighborhoods with the most overdose dispatches based on rate of calls per 10,000 for 2015-
2018 in Allegheny County, PA (post intervention) 
 











Shaler Township 216 639 676.06 34.26% 
Golden Triangle 878 3629 483.88 77.56% 
North Shore 61 303 402.64 65.57% 
East Allegheny 189 2136 176.97 62.96% 
Middle Hill 132 1707 154.66 79.55% 
Strip District 41 616 133.12 73.17% 
Braddock 139 2172 127.99 73.38% 
South Side Flats 23 362 127.07 78.26% 
Allegheny Center 415 6597 125.82 66.27% 










Overdose 911 Calls 
2011-2014 
2010 Census Data Rate of Calls per 
10,000 
Penn Hills 320 42,329 15.12 
McKeesport 249 19,731 25.24 
Carrick 210 10,113 41.53 
Wilkinsburg 200 15,930 25.11 
Golden Triangle 197 3,629 108.57 
Ross Township 151 31,105 9.71 
Shaler Township 142 639 444.44 
South Side Flats 140 6,597 42.44 
Stowe 133 6,362 41.81 
Brentwood 133 9,643 27.58 
 
 
















Golden Triangle 905 3,629 483.88 345.69 
Penn Hills 499 42,329 22.96 51.88 
Carrick 471 10,113 91.37 120.00 
McKeesport 462 19,731 45.11 78.71 
South Side Flats 430 6,597 125.81 196.43 
Wilkinsburg 294 15,930 35.03 39.50 




8,799 51.82 93.22 
West Mifflin 229 20,313 21.96 79.84 





Table 5 Interuppted Time Series Model Output for Overdose Related Dispatches from 2011-2018 







y-intercept .0000262 5.61e-06 4.68 0.000 .0000148 - .0000377 
First year 
Slope 
.0011766 .0008286  1.42 0.167 -.0005206 - .0028739 
Second year 
Slope 
.0000374 .000086  0.43 0.667  -.0001388 - .0002136  
Overall 
Slope 
.002783 .0000421  66.15 0.000 .0026969 - .0028692 
 

































Table 7 Spearman Correlations of Opioid related overdose deaths and Overdose Related Dispatches using 
monthly aggregrated counts in Allegheny County, PA 2011-2018 
 
Annual Intervals (monthly 
aggregated counts from January 
to December) 
Overdose related 911 Dispatches 
Opioid Deaths 2011 (n=12) r=0.22144 (p=0.49) 
Opioid Deaths 2012 (n=12) r=-0.11972 (p=0.71) 
Opioid Deaths 2013 (n=12) r=-0.23011 (p=0.47)  
Opioid Deaths 2014 (n=12) r=0.41595 (p=0.18)  
Opioid Deaths 2015 (n=12) r=-0.14737 (p=0.64)  
Opioid Deaths 2016 (n=12) r=0.91419 (p=<0.0001)  
Opioid Deaths 2017 (n=12) r=0.76056 (p=0.004)  
Opioid Deaths 2018 (n=12) r=0.44491 (p=0.15)  
Opioid Deaths 2011-2014 (n=48) r=0.17485 (p=0.24)  
Opioid Deaths 2015-2018 (n=48) r=0.72757 (p=<0.0001)  












Table 8 Quarterly Counts of Opioid related overdose deaths and Overdose Related 911 Dispatches in 
Allegheny County, PA 2011-2018 
 







Volume of Calls 
Opioid Related 
2011 Q1 50 438 161,452 0.27 
2011 Q2 64 541 182,010 0.30 
2011 Q3 38 515 190,646 0.27 
2011 Q4 54 471 171,631 0.27 
2012 Q1 52 556 171,693 0.32 
2012 Q2 64 477 183,050 0.26 
2012 Q3 50 579 186,501 0.31 
2012 Q4 60 577 169,394 0.34 
2013 Q1 62 508 171,962 0.30 
2013 Q2 59 496 195,026 0.25 
2013 Q3 51 553 196,943 0.28 
2013 Q4 54 544 175,591 0.31 
2014 Q1 66 588 176,168 0.33 
2014 Q2 49 593 197,620 0.30 
2014 Q3 54 615 201,809 0.30 
2014 Q4 72 626 183,999 0.34 
2015 Q1 93 598 181,276 0.33 
2015 Q2 111 751 204,632 0.37 
2015 Q3 67 754 210,248 0.36 
2015 Q4 81 773 194,050 0.40 
2016 Q1 79 814 191,865 0.42 
2016 Q2 109 963 211,198 0.46 
2016 Q3 155 1,314 215,776 0.61 
2016 Q4 216 1,482 199,146 0.74 
2017 Q1 206 1,329 196,494 0.68 
2017 Q2 161 1,374 216,750 0.63 
2017 Q3 147 1,360 222,713 0.61 
2017 Q4 110 956 208,919 0.46 
2018 Q1 75 825 209,470 0.39 
2018 Q2 111 990 227,127 0.44 
2018 Q3 78 1,064 234,163 0.45 























Figure 1 Overdose related dispatches counts aggregated quarterly for Allegheny County from 2011-2018 
 
Figure 2 Volume of overdose related dispatches aggregated quarterly 
The volume of overdoses related dispatches is the number of overdose related dispatches over the total number 
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Figure 6 Graph of the outcome of the interrupted time series model 
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